Overview

A Methodology Development Clinical Trial of Reproxalap in Subjects With Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber

Status:
Completed

Trial end date:
2019-03-20

Target enrollment:

Participant gender:

Summary

An Exploratory Clinical Trial Evaluating Reproxalap Ophthalmic Solutions (0.25% and 0.5%) in Subjects with Seasonal Allergic Conjunctivitis Using the Environmental Exposure Chamber (EEC)

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Aldeyra Therapeutics, Inc.

Treatments:

Ophthalmic Solutions
Pharmaceutical Solutions